Combat veterans fight for recognition and care, while a new drug emerges as a possible solution for PTSD.
A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight ...
Verdict Overall Experience: 4.9 / 5 Best For: Patients seeking affordable semaglutide and tirzepatide access Semaglutide ...
A pivotal step in PharmaEssentia's dual-site U.S.-Taiwan manufacturing strategy, with 2027 operations in sight ...
A Cincinnati-based research team has built a generative AI virtual assistant designed to help nonphysician clinicians ...